Abstract
The role of macrophages (MΦs) remains incompletely understood in kidney injury and repair. The plasticity of MΦs offers an opportunity to polarize them toward mediating injury resolution in both native and transplanted kidneys undergoing ischemia and/or rejection. Here, we show that infiltrating kidney MΦs augmented their own allograft inflammatory factor 1 (AIF-1) expression after injury. Aif1 genetic deletion led to MΦ polarization toward a reparative phenotype while halting the development of kidney fibrosis. The enhanced repair was mediated by higher levels of antiinflammatory and proregenerative markers, leading to a reduction in cell death and an increase in proliferation of kidney tubular epithelial cells after ischemia followed by reperfusion injury (I/RI). Adoptive transfer of Aif1-/- MΦs into Aif1+/+ mice conferred protection against I/RI. Conversely, depletion of MΦs reversed the tissue-reparative effects in Aif1-/- mice. We further demonstrated increased expression of AIF-1 in human kidney biopsies from native kidneys with acute kidney injury or chronic kidney disease, as well as in biopsies from kidney allografts undergoing acute or chronic rejection. We conclude that AIF-1 is a MΦ marker of renal inflammation, and its targeting uncouples MΦ reparative functions from profibrotic functions. Thus, therapies inhibiting AIF- 1 when ischemic injury is inevitable have the potential to reduce the global burden of kidney disease.
| Original language | English (US) |
|---|---|
| Article number | e185146 |
| Journal | Journal of Clinical Investigation |
| Volume | 135 |
| Issue number | 5 |
| DOIs | |
| State | Published - Mar 3 2025 |
Funding
This work was supported by an American Society of Nephrology Ben J Lipps Research Fellowship (to IH) and NIH grant R01HL139812 (to XL). We thank the Henry E. Haller Jr. Foundation for their generous support of this work (to XL). In addition, we would like to thank Robert Fairchild and Karen Keslar for their assistance with NanoString data analysis, both of whom are supported by NIH UO1 grant AI063594 for the Clinical Trials in Organ Transplantation (CTOT) NanoString Core.
ASJC Scopus subject areas
- General Medicine